Tadashi Mio

4.9k total citations
156 papers, 3.8k citations indexed

About

Tadashi Mio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tadashi Mio has authored 156 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 82 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Tadashi Mio's work include Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (38 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Tadashi Mio is often cited by papers focused on Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (38 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Tadashi Mio collaborates with scholars based in Japan, United States and Italy. Tadashi Mio's co-authors include Kohei Fujita, Debra J. Romberger, Stephen I. Rennard, Michiaki Mishima, Young Hak Kim, Osamu Kanai, Katsuhiro Masago, Richard Robbins, Koichi Nakatani and Yuichi Adachi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Tadashi Mio

148 papers receiving 3.7k citations

Peers

Tadashi Mio
Panagiotis Paliogiannis Italy
Kazuo Kasahara Japan
Hiroshi Kagamu Japan
Hiroshi Kida Japan
Haibo Qiu China
Chul Won Jung South Korea
Kazunari Tanabe Japan
Michele Nichelatti Italy
Marion Haubitz Germany
Jeffrey Crawford United States
Panagiotis Paliogiannis Italy
Tadashi Mio
Citations per year, relative to Tadashi Mio Tadashi Mio (= 1×) peers Panagiotis Paliogiannis

Countries citing papers authored by Tadashi Mio

Since Specialization
Citations

This map shows the geographic impact of Tadashi Mio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Mio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Mio more than expected).

Fields of papers citing papers by Tadashi Mio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Mio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Mio. The network helps show where Tadashi Mio may publish in the future.

Co-authorship network of co-authors of Tadashi Mio

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Mio. A scholar is included among the top collaborators of Tadashi Mio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Mio. Tadashi Mio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuboi, Masahiro, Haruyasu Murakami, Hideyuki Harada, et al.. (2024). Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study. Thoracic Cancer. 15(20). 1541–1552. 1 indexed citations
2.
Fujita, Kohei, Toshiyuki Iwata, Osamu Kanai, et al.. (2023). Clinical features of pneumothorax associated with COVID-19: A retrospective analysis of two centres. Respiratory Investigation. 62(1). 137–141.
3.
Kanai, Osamu, et al.. (2023). Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report. SHILAP Revista de lepidopterología. 16(1). 1100–1106. 2 indexed citations
4.
5.
Fujita, Kohei, et al.. (2020). Impact of COVID ‐19 pandemic on lung cancer treatment scheduling. Thoracic Cancer. 11(10). 2983–2986. 32 indexed citations
6.
Hata, Hiroki, et al.. (2020). Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey. Cancer Control. 27(4). 544337976–544337976. 5 indexed citations
7.
Horinouchi, Hidehito, Shinji Atagi, Satoshi Oizumi, et al.. (2020). Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study. Cancer Medicine. 9(18). 6597–6608. 31 indexed citations
8.
Uchida, Naohiro, et al.. (2018). Nivolumab‐induced severe acute kidney injury with a long latent phase in a patient with non‐small‐cell lung cancer: A case report. Clinical Case Reports. 6(11). 2185–2188. 9 indexed citations
9.
Kanai, Osamu, Young Hak Kim, Koichi Nakatani, Kohei Fujita, & Tadashi Mio. (2017). Nasogastric tube‐administered alectinib achieved long‐term survival in a crizotinib‐refractory nonsmall cell lung cancer patient with a poor performance status. Clinical Case Reports. 5(6). 927–930. 4 indexed citations
10.
Togashi, Yosuke, Katsuhiro Masago, Takeshi Kubo, et al.. (2010). Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer. 117(4). 819–825. 55 indexed citations
11.
Togashi, Yosuke, Katsuhiro Masago, Masahide Fukudo, et al.. (2010). Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis. Journal of Thoracic Oncology. 5(5). 601–605. 42 indexed citations
12.
Masago, Katsuhiro, Shiro Fujita, Yukimasa Hatachi, et al.. (2009). Effect of vascular endothelial growth factor polymorphisms on survival in advanced‐stage non‐small‐cell lung cancer. Cancer Science. 100(10). 1917–1922. 32 indexed citations
13.
Kim, Young Hak, et al.. (2009). Successful treatment with carboplatin and etoposide in a small-cell lung cancer patient undergoing hemodialysis. Respiratory Medicine CME. 3(2). 68–70. 1 indexed citations
14.
Masago, Katsuhiro, Ryo Asato, Shiro Fujita, et al.. (2008). Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma. International Journal of Cancer. 124(11). 2744–2749. 40 indexed citations
15.
16.
Fujita, Shiro, Nobuyuki Katakami, Yutaka Takahashi, et al.. (2006). Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery. 29(6). 896–901. 34 indexed citations
17.
Miki, Hiroyuki, Tadashi Mio, Sonoko Nagai, et al.. (2000). Fibroblast Contractility. American Journal of Respiratory and Critical Care Medicine. 162(6). 2259–2264. 30 indexed citations
18.
Mio, Tadashi, Debra J. Romberger, A. Thompson, et al.. (1997). Cigarette Smoke Induces Interleukin-8 Release From Human Bronchial Epithelial Cells. American Journal of Respiratory and Critical Care Medicine. 155(5). 1770–1776. 344 indexed citations
19.
Nakamura, Yoichi, Debra J. Romberger, Larry G. Tate, et al.. (1995). Cigarette Smoke Inhibits Lung Fibroblast Proliferation and Chemotaxis. American Journal of Respiratory and Critical Care Medicine. 151(5). 1497–1503. 139 indexed citations
20.
Mio, Tadashi, et al.. (1992). Proliferative Characteristics of Fibroblast Lines Derived from Open Lung Biopsy Specimens of Patients with IPF (UIP). CHEST Journal. 102(3). 832–837. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Panagiotis Paliogiannis Breakdown of academic impact, for papers by Kazuo Kasahara Breakdown of academic impact, for papers by Hiroshi Kagamu Breakdown of academic impact, for papers by Hiroshi Kida Breakdown of academic impact, for papers by Haibo Qiu Breakdown of academic impact, for papers by Chul Won Jung Breakdown of academic impact, for papers by Kazunari Tanabe Breakdown of academic impact, for papers by Michele Nichelatti Breakdown of academic impact, for papers by Marion Haubitz Breakdown of academic impact, for papers by Jeffrey Crawford
Rankless by CCL
2026